dsm-firmenich boosts HMO portfoliodsm-firmenich has announced that it has received ‘no questions’ response letters from the US Food and Drug Administration (FDA) to its Generally Recognized as Safe (GRAS) notices submitted by Glycom A/S* for three new human milk oligosaccharide (HMO) ingredients. Ingredients
DSM’s HMO (2FL) gains regulatory approval for early life nutrition in CanadaHMOs are a component of human milk, and growing evidence shows that they have important immunity and gut health benefits, and a potential role in brain and cognitive development. Dairy science, Ingredients